David A. Siegel Volitionrx LTD Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding VNRX
# of Institutions
30Shares Held
24.1MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY11.7MShares$4.45 Million5.2% of portfolio
-
Armistice Capital, LLC New York, NY8.49MShares$3.23 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.53MShares$581,4180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA765KShares$290,6580.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$196,1070.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $21.8M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...